Boggi U, Coletti L, Vistoli F, Del Chiaro M, Signori S, Croce C, Bartolo T Vanadia, Pietrabissa A, Marchetti P, Capocasale E, Dalla Valle R, Mazzoni M P, Mosca F
Divisione di Chirurgia Generale e Trapianti, Università di Pisa, Pisa, Italy.
Transplant Proc. 2004 Apr;36(3):563-5. doi: 10.1016/j.transproceed.2004.03.078.
Although the use of Celsior has been recently described for heart, lung, liver, and kidney transplantation, no data are available on its use for clinical pancreas preservation.
We herein describe the results of 112 pancreas transplants preserved with either University of Wisconsin (UW; (n = 56) or Celsior (n = 56) solution at two Italian transplant centers. The groups were comparable with regard to all donor and recipient characteristics.
Mean cold and warm ischemia times were 10.1 +/- 2.2 hours and 37.2 +/- 8.2 minutes for UW compared to 10.8 +/- 2.4 hours and 38.3 +/- 6.7 minutes for Celsior (P = NS). Delayed endocrine pancreas function was recorded in two UW-preserved grafts (3.6%). Actuarial 1-year patient survival was 94.6% for UW as compared with 100% for Celsior (P = NS). Equivalent graft survival figures were 91.0% for UW as compared with 96.4% for Celsior (P = NS).
Within the range of cold ischemia times reported in this study, UW and Celsior solutions have similar safety profiles for pancreas transplantation.
尽管最近已有关于Celsior溶液用于心脏、肺、肝脏和肾脏移植的报道,但尚无其用于临床胰腺保存的数据。
我们在此描述了在两个意大利移植中心用威斯康星大学(UW;n = 56)或Celsior溶液(n = 56)保存的112例胰腺移植的结果。两组在所有供体和受体特征方面具有可比性。
UW组的平均冷缺血时间和热缺血时间分别为10.1±2.2小时和37.2±8.2分钟,而Celsior组分别为10.8±2.4小时和38.3±6.7分钟(P =无显著性差异)。在两个用UW溶液保存的移植物中记录到延迟的内分泌胰腺功能(3.6%)。UW组1年患者精算生存率为94.6%,而Celsior组为100%(P =无显著性差异)。UW组和Celsior组的移植物生存率相当,分别为91.0%和96.4%(P =无显著性差异)。
在本研究报道的冷缺血时间范围内,UW溶液和Celsior溶液在胰腺移植方面具有相似的安全性。